Results 11 to 20 of about 28,537 (233)

Poppies as a sleep aid for infants: The “Hypnos” remedy of Cretan folk medicine

Toxicology Reports, 2021
Opium Poppy (Papaver somniferum L.) is considered as one of the earliest medicinal plants known to mankind. Derived from the Greek name “opos” meaning juice, referring to its psychotropic latex, the plant was known and extensively used since Antiquity ...
Kleopatra Mathianaki, Manolis Tzatzarakis, Marianna Karamanou   +2 more
doaj   +1 more source

Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges

Pharmaceuticals, 2022
Cannabidiol (CBD), a major non-psychotropic component of cannabis, is receiving growing attention as a potential anticancer agent. CBD suppresses the development of cancer in both in vitro (cancer cell culture) and in vivo (xenografts in immunodeficient ...
Miguel Olivas-Aguirre, Liliana Torres-López, Kathya Villatoro-Gómez, Sonia Mayra Perez-Tapia, Igor Pottosin, Oxana Dobrovinskaya   +5 more
doaj   +1 more source

Symptomatic Profile of Cariprazine in the Context of ICD-11 Domains for Schizophrenia: Review of Clinically Oriented Studies [PDF]

Consortium Psychiatricum, 2022
INTRODUCTION: One of the innovations in the ICD-11grouping "Schizophrenia and Other Primary Psychotic Disorders" is the implementation of six symptom domains intended to improve diagnostics and treatment of these mental conditions in clinical practice ...
Alexey Viktorovich Pavlichenko, Anna Sergeevna Gubina   +1 more
doaj   +1 more source

Cannabidiol and periodontal inflammatory disease: A critical assessment

Biomedical Papers, 2022
Cannabidiol (CBD), a non-psychotropic cannabinoid produced by the genus Cannabis, is a phytoceutical that activates the endocannabinoid system (ECS) through binding to CB1 and CB2 receptors.
Petr Jirasek, Alexandr Jusku, Vilim Simanek, Jana Frankova, Jan Storch, Jan Vacek   +5 more
doaj   +1 more source

Idiopathic serontonin syndrome. Can we prevent it?

European Psychiatry, 2022
Introduction Serotonin syndrome is a mild to potentially life-threatening syndrome associated with excessive serotonergic activity within the central nervous system.
L. Gallardo Borge, I.D.L.M. Santos Carrasco, P. Marqués Cabezas, L. Rodriguez Andrés, A. Rodriguez Campos   +4 more
doaj   +1 more source

Drosophila modifier screens to identify novel neuropsychiatric drugs including aminergic agents for the possible treatment of Parkinson's disease and depression. [PDF]

, 2014
Small molecules that increase the presynaptic function of aminergic cells may provide neuroprotection in Parkinson's disease (PD) as well as treatments for attention deficit hyperactivity disorder (ADHD) and depression.
Biedermann, T, Chou, M-T, Djapri, C, Hadi, R, Huang, B, Jang, J, Krantz, DE, Lam, HA, Lawal, HO, Lawless, GM, Maidment, NT, Roberts, L, Shahi, V, Terrell, A   +13 more
core   +2 more sources

Influence of Antipsychotic Agents on the Sexuality of Patients Diagnosed with Schizophrenia

Current Therapeutic Research, 2023
: Background: Sexuality is a natural component of human behavior. The general population has been extensively studied since the first half of the 20th century.
Jaballah Fares, Ferhi Mohamed, Zgueb Yosra, Hazem Oumaya, Bouzid Riadh, Mannaii Jihenne   +5 more
doaj   +1 more source

Incidence and correlates of delirium in a West African mental health clinic [PDF]

, 2010
Objective: <br/> <br/> To determine the incidence of delirium in those patients presenting to a psychiatric clinic in Nigeria and to examine if any demographic or clinical variables were correlated with this diagnosis. <br/> <br/
Abiodun, Abiodun, Abiodun, Adamis, Adebayo Rasheed Erinfolami, Adeyemi, Aghanwa, Aghanwa, Andrew Olagunju, APA, Armstrong, Bolanle Adeyemi Ola, Brown, Burns, Cole, Cookson, Francis, Inouye, Jim Crabb, Kiely, Kishi, Koran, Koranyi, Meagher, Melka, Nubukpo, Pompei, Rajeev Krishnadas, Rockwood, Rolfson, Semple, Siddiqi, Sirois, SPSS Inc., Swigart, Taylor, Trzepacz, Trzepacz, van Hemert, Vanpee, Waszynski, Wei, WHO, WHO, WHO, Zou   +45 more
core   +1 more source

Use of apomorphine in Parkinsonian patients with neuropsychiatric complications to oral treatment [PDF]

, 1997
Neuropsychiatric side effects often complicate anti-Parkinsonian therapy and pose a significant problem in the optimal management of idiopathic Parkinson's disease.
Abbott, R.J., Chaudhuri, K.R., Ellis, C, Leigh, P.N., Lemmens, Gilbert, Parkes, J.D., Pye, I.F.   +6 more
core   +2 more sources

The polysemy of psychotropic drugs: continuity and overlap between neuroenhancement, treatment, prevention, pain relief, and pleasure-seeking in a clinical setting

BMC Medical Ethics, 2020
Background Enhancement involves the use of biomedical technologies to improve human capacities beyond therapeutic purposes. It has been well documented that enhancement is sometimes difficult to distinguish from treatment.
Eisuke Sakakibara
doaj   +1 more source